Top Markets
#1 Akedo Akedo +58.73%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +47.62%
#4 Velvet Velvet +38.36%
#5 Black Phoenix Black Phoenix +33.94%
#6 Cross Cross +27.05%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +17.76%
#8 QANplatform QANplatform +14.60%
#9 Perle Perle +14.17%
#10 Bitway Bitway +13.96%
Coin of the day
Akedo Akedo
Settings
Language
ENGLISH
Currency
USD
Theme
Pideka Group Inc. Pideka Group Inc.

Pideka Group Inc.

CIMVF
Rank in Stocks #38579
Ikänik Farms, Inc. operates as a comprehensive, vertically integrated... Ikänik Farms, Inc. operates as a comprehensive, vertically integrated enterprise within the cannabis industry, handling everything from cultivation and processing to distribution and managing retail dispensaries. Its operations are established in both California and Colombia. The firm provides a diverse selection of cannabis-derived products, which includes pharmaceutical-grade cannabinoids, decarboxylated plant material, completed cannabidiol (CBD) items, and ready-to-use ingredient cannabis oil. These offerings are available for both scientific research and broader commercial markets. The company distributes its products through a range of distinct brands, namely Ikanik, Essentials, Ronen, and Rations. Its main corporate office is located in Toronto, Canada.
Share Price
$0.0111
Last synced: 2023-05-23
Market Cap
$902.96K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
CA
Trade Pideka Group Inc. (CIMVF)

Category

Healthcare
P/E ratio for Pideka Group Inc. (CIMVF)
P/E ratio as of 2026 TTM: 0
According to Pideka Group Inc. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Pideka Group Inc. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 41.61 -
IN
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.